Axsome Therapeutics, Inc. has three marketed CNS drugs and pipeline potential in Alzheimer's and narcolepsy. Read why AXSM stock is a buy.
Morning Overview on MSN
This aviation stock could turn $100K into $1M, analysts whisper
Wall Street’s renewed appetite for aviation risk is colliding with a powerful travel rebound, and a handful of names are ...
Nuclear energy is enjoying a renaissance in the U. S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results